Literature DB >> 35394606

Dermatofibrosarcoma Protuberans in Children.

Aseel Sleiwah1, Thomas C Wright2, Thomas Chapman2, Adam Dangoor3, Francesca Maggiani2,4, Rachel Clancy2.   

Abstract

OPINION STATEMENT: Paediatric dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue malignant tumour which displays aggressive local behaviour and has low metastatic potential. The diagnosis is often delayed as DFSP is usually mistaken for other skin conditions, particularly in the early stages of disease. DFSP tends to follow an indolent course after the initial presentation with what is often described as a "rubbery lump". As the disease progresses, the lump tends to enlarge, change colour, and exhibit a more nodular consistency. In rare cases, DFSP can present as an ulcerated exophytic lesion or a depressed area of skin, making diagnosis even more challenging. A high index of suspicion is warranted for early diagnosis, and referral to a specialist unit with expertise in both oncologic resection and reconstruction. DFSP tumours arise from the dermis and grow with finger-like projections. Therefore, in cosmetically sensitive or functionally important locations, an excision and analysis technique that assesses all excision margins is the gold standard of care. Slow Mohs technique performed with en bloc excision is a well-tolerated option for oncologic resection of the tumour. Mohs technique can also be considered but can be challenging in children for reasons explained below. As an alternative, depending on the anatomical location, tumours can be excised with a wide local excision. While an excision technique that incorporates the deep fascia with a 3-cm peripheral margin is acceptable in adults, planning of the excision margin in children should involve consideration of preoperative imaging with MRI, site of the tumour, age, and physical built of the child. Patients should be offered all treatment options considering the local outcomes, available expertise, and cost. A multidisciplinary approach and good communication between team members is crucial. Close collaboration with a pathologist who is familiar with sectioning technique that allows margin control is of paramount importance. Soft tissue reconstruction should be performed immediately after oncologic clearance, although a staged approach may be required. Adjuvant radiotherapy should be avoided in children due to the long-term risk of secondary malignancies and potential for growth disruption.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cutaneous surgery; Dermatofibrosarcoma; Paediatric dermatofibrosarcoma; Skin tumours; Soft tissue sarcoma

Mesh:

Year:  2022        PMID: 35394606     DOI: 10.1007/s11864-022-00979-9

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  50 in total

1.  Dermatofibrosarcoma protuberans. A study of 115 cases.

Authors:  H B TAYLOR; E B HELWIG
Journal:  Cancer       Date:  1962 Jul-Aug       Impact factor: 6.860

2.  Childhood dermatofibrosarcoma protuberans: role of preoperative imaging.

Authors:  Sharon Longshore Thornton; Janet Reid; Francis A Papay; Allison T Vidimos
Journal:  J Am Acad Dermatol       Date:  2005-07       Impact factor: 11.527

3.  Incidence and Outcomes of Dermatofibrosarcoma Protuberans in the US Pediatric Population.

Authors:  Gustavo A Rubio; Andrea Alvarado; David J Gerth; Jun Tashiro; Seth R Thaller
Journal:  J Craniofac Surg       Date:  2017-01       Impact factor: 1.046

4.  Paediatric dermatofibrosarcoma protuberans (DFSP): Evaluation of a rare childhood malignancy, the Welsh experience.

Authors:  Alexandra Gordon; Jonathan J Cubitt; Nicholas Wilson-Jones
Journal:  J Plast Reconstr Aesthet Surg       Date:  2017-07-26       Impact factor: 2.740

5.  Pediatric dermatofibrosarcoma protuberans in Madrid, Spain: multi-institutional outcomes.

Authors:  Marta Valdivielso-Ramos; Antonio Torrelo; Minia Campos; Marta Feito; Reyes Gamo; Jose Luis Rodriguez-Peralto
Journal:  Pediatr Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.588

6.  Congenital dermatofibrosarcoma protuberans: variability in presentation.

Authors:  Jill M Weinstein; Beth A Drolet; Nancy B Esterly; Maureen Rogers; Bruce S Bauer; Annette M Wagner; Anthony J Mancini
Journal:  Arch Dermatol       Date:  2003-02

7.  Dermatofibrosarcoma protuberans in pediatric patients: a report of 17 cases.

Authors:  Claudia J Posso-De Los Rios; Irene Lara-Corrales; Nhung Ho
Journal:  J Cutan Med Surg       Date:  2014 May-Jun       Impact factor: 2.092

8.  Dermatofibrosarcoma protuberans in children.

Authors:  Chaitan Reddy; Peter Hayward; Phillip Thompson; Alex Kan
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-12-21       Impact factor: 2.740

9.  Dermatofibrosarcoma protuberans (DFSP) in children: A combined multidisciplinary approach.

Authors:  Aseel Sleiwah; Cristina Psomadakis; Emma Craythorne; Catherine M Stefanato; William Rickaby; Alistair Robson; Jemima E Mellerio; Aina Greig
Journal:  Pediatr Dermatol       Date:  2020-11-11       Impact factor: 1.588

Review 10.  The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives.

Authors:  Marta Sbaraglia; Elena Bellan; Angelo P Dei Tos
Journal:  Pathologica       Date:  2020-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.